Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

A randomized controlled trial of Botulinum toxin on lower limb spasticity following acute acquired severe brain injury [with consumer summary]
Verplancke D, Snape S, Salisbury CF, Jones PW, Ward AB
Clinical Rehabilitation 2005 Mar;19(2):117-125
clinical trial
4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVE: To determine whether serial casting combined with Botulinum toxin reduces the development of calf contracture after severe head injury. DESIGN: A double-blind placebo-controlled trial of three parallel treatments for lower limb spasticity. SETTING: Acute general hospital in the UK. SUBJECTS: Adults aged 17 to 70 years admitted to hospital following a severe brain injury. INTERVENTIONS: Current physical treatment (group I), lower leg casting plus injections with either saline (group II), or with Botulinum toxin (group III) into gastrocnemius and soleus muscles. MEASURES: Limit of ankle dorsiflexion at entry and exit after up to 12 weeks, the Glasgow Outcome Scale (GOS) and Modified Ashworth Scale (MAS). RESULTS: Two hundred and fifty-three patients were screened and 35 were entered into the trial. Three patients died and four failed to complete the trial. Eighty-eight per cent of those entering the randomized part of the study developed spasticity within 14 days of their injury and the mean range of improvement in the angle of passive ankle dorsiflexion was 4.59 degrees in controls, 11.69 degrees in cast and saline and 13.59 degrees in cast and Botulinum toxin. There were significant improvements in the MAS scores in actively treated groups, but not in controls. Cast and Botulinum toxin patients also demonstrated a significant improvement in the GOS. CONCLUSIONS: Active intervention with casting prevents talipes equinovarus deformities in patients losing ankle movement following severe brain injury. Casting alone in these patients is sufficient; the role of additional Botulinum toxin needs further investigation, but is safe in these patients.

Full text (sometimes free) may be available at these link(s):      help